HRS-2329

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-2329, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications [Phase 1]

See pricing